speb/financial-data huggingface dataset:
Financial ratios for MARA — quarterly report dated 2025-03-31
Total revenue: 213884000
Gross profit: 170403000
Operating income: -173729000
Net income: -533199000
Capital expenditures: 35384000
Operating cash flow: -215488000
Depreciation & amortization: 157897000
Net tangible assets: 3639544000
Owner earnings: -410686000
Return on net tangible assets (%): -11.283996017083458
Buffett classification: The Gruesome
Stock price: 11.5
Shares outstanding: 381270503
Book value: 3728680000
P/B ratio: 1.1759150113444974
Market cap (USD): 4384610784.5
Debt to equity: 0.7071124365727282
Current ratio: 0.7922089203789668
Quick ratio: 0.7922089203789668
Interest coverage ratio: -17.476008449854138
COGS to revenue (%): 20.329243889210975
R&D to revenue (%): 4.347216248059696
SG&A to revenue (%): 40.1455929382282
Free cash flow (dilution-adjusted): -303459000
Buyback yield (%): 0
Retained earnings: -559586000
Receivables turnover: 24.789522484932778
Capitalized R&D asset: 9298000
ROCI (R&D-adjusted, %): -2.752999788235421
FCF margin (%): -141.88017804043312
Rule of 40 score: -141.88017804043312
Financial ratios for MARA — quarterly report dated 2025-06-30
Total revenue: 238485000
Gross profit: 196755000
Operating income: -160308000
Net income: 808235000
Capital expenditures: 118713000
Operating cash flow: -163443000
Depreciation & amortization: 161741000
Net tangible assets: 4706727000
Owner earnings: 851263000
Return on net tangible assets (%): 18.086092522468373
Buffett classification: The Gruesome
Stock price: 15.68
P/E ratio: 21.736505355807967
Shares outstanding: 381270503
Book value: 4796212000
P/B ratio: 1.2464673135883066
Market cap (USD): 5978321487.04
Debt to equity: 0.5515415081735336
Current ratio: 0.5361548229105256
Quick ratio: 0.5361548229105256
Effective tax rate (%): 20.507736235245286
Interest coverage ratio: -12.489910401246592
COGS to revenue (%): 17.497955846279638
R&D to revenue (%): 3.5834538859886362
SG&A to revenue (%): 38.97435897435898
Free cash flow (dilution-adjusted): -337014000
Buyback yield (%): 0
Retained earnings: 248649000
Receivables turnover: 7.68661767549797
Capitalized R&D asset: 14775660
ROCI (R&D-adjusted, %): -2.1618328348579885
Rosenberg metric: 2.8341578834157883
FCF margin (%): -141.3145480847852
Revenue growth (%): 11.502029137289371
Rule of 40 score: -129.81251894749582
Financial ratios for MARA — quarterly report dated 2025-09-30
Total revenue: 252410000
Gross profit: 209330000
Operating income: -156322000
Net income: 123134000
Capital expenditures: 84828000
Operating cash flow: -199049000
Depreciation & amortization: 167312000
Net tangible assets: 5074789000
Owner earnings: 205618000
Return on net tangible assets (%): 4.051754664085541
Buffett classification: The Gruesome
Stock price: 18.26
P/E ratio: 17.48499230173042
Shares outstanding: 381270503
Book value: 5175012000
P/B ratio: 1.3453107712175354
Market cap (USD): 6961999384.780001
Debt to equity: 0.7038576915377202
Current ratio: 2.093998097398399
Quick ratio: 2.093998097398399
Effective tax rate (%): 23.42984354401413
Interest coverage ratio: -12.250940438871474
COGS to revenue (%): 17.0674695931223
R&D to revenue (%): 3.453112000316945
SG&A to revenue (%): 33.792638960421534
Free cash flow (dilution-adjusted): -322343000
Buyback yield (%): 0
Retained earnings: 371777000
Receivables turnover: 7.621074879227053
Capitalized R&D asset: 17510160
ROCI (R&D-adjusted, %): -1.796005775111061
Rosenberg metric: 1.4714486309384507
FCF margin (%): -127.70611307000515
Revenue growth (%): 5.838941652514833
Rule of 40 score: -121.86717141749031
Financial ratios for MARA — annual report dated 2025-12-31
Total revenue: 907093000
Gross profit: 728052000
Operating income: -822169000
Net income: -1311480000
Capital expenditures: 403417000
Operating cash flow: -802725000
Depreciation & amortization: 772768000
Net tangible assets: 3470732000
Owner earnings: -942129000
Return on net tangible assets (%): -27.14496538482372
Buffett classification: The Gruesome
Stock price: 8.98
Shares outstanding: 381270503
Book value: 3477090000
P/B ratio: 0.984676587876644
Market cap (USD): 3423809116.94
Debt to equity: 1.0483919024241535
Current ratio: 1.272848862275449
Quick ratio: 1.272848862275449
Interest coverage ratio: -16.9936338645336
COGS to revenue (%): 19.737887956361696
R&D to revenue (%): 3.320166730423452
SG&A to revenue (%): 38.57829351565936
Free cash flow (dilution-adjusted): -1382091000
Buyback yield (%): 0
Retained earnings: -1337867000
Receivables turnover: 48.92626752966559
Capitalized R&D asset: 39908390
ROCI (R&D-adjusted, %): -11.865481590773012
Rosenberg metric: 12.838007407967345
FCF margin (%): -152.36486225778393
Revenue growth (%): 38.19674029294096
Rule of 40 score: -114.16812196484297
Financial ratios for MARA — quarterly report dated 2025-12-31
Total revenue: 202314000
Gross profit: 151564000
Operating income: -331810000
Net income: -1709376000
Capital expenditures: 164472000
Operating cash flow: -224745000
Depreciation & amortization: 285818000
Net tangible assets: 3470732000
Owner earnings: -1588030000
Return on net tangible assets (%): -45.754901271547325
Buffett classification: The Gruesome
Stock price: 8.98
Shares outstanding: 381270503
Book value: 3477090000
P/B ratio: 0.984676587876644
Market cap (USD): 3423809116.94
Debt to equity: 1.0483919024241535
Current ratio: 1.272848862275449
Quick ratio: 1.272848862275449
Interest coverage ratio: -25.831841183339822
COGS to revenue (%): 25.084769220123178
R&D to revenue (%): 1.7581581106596675
SG&A to revenue (%): 42.42514111727315
Free cash flow (dilution-adjusted): -419275000
Buyback yield (%): 0
Retained earnings: -1337867000
Receivables turnover: 10.912297734627831
Capitalized R&D asset: 12216900
ROCI (R&D-adjusted, %): -4.945857342427752
Rosenberg metric: -6.627581459385039
FCF margin (%): -207.23973625156935
Revenue growth (%): -19.84707420466701
Rule of 40 score: -227.08681045623638
Financial ratios for MEDI.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.88939566704675
Shares outstanding: 18282848
Market cap (USD): 674443213.7924743
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDI.OL — annual report dated 2022-12-31
Total revenue: 49216801.619433194
Gross profit: 38438866.396761134
Operating income: 14296457.48987854
Net income: 11535728.74493927
Capital expenditures: 936336.0323886639
Operating cash flow: 11486943.319838056
Depreciation & amortization: 2357085.020242915
Net tangible assets: 33565182.18623482
Owner earnings: 12956477.732793521
Return on net tangible assets (%): 38.60094564928956
Capex to operating income (%): 6.5494268985975115
Buffett classification: The Great
Stock price: 20.884615384615383
P/E ratio: 33.09979430496697
Shares outstanding: 18282848
Book value: 37215789.47368421
P/B ratio: 10.2598991991123
Market cap (USD): 381830248.6153846
Debt to equity: 0.04652263307333311
Current ratio: 3.865821161667769
Quick ratio: 2.7204524052814008
Effective tax rate (%): 21.963176742052326
Interest coverage ratio: 366.88051948051947
COGS to revenue (%): 21.898894011870144
SG&A to revenue (%): 8.131007563823617
Free cash flow (dilution-adjusted): 9351113.360323885
Buyback yield (%): 0
Retained earnings: 28920748.98785425
Inventory turnover: 0.9313671468429936
Receivables turnover: 4.783359729285736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.89533665763758
FCF margin (%): 18.999839592647586
Rule of 40 score: 18.999839592647586
Financial ratios for MEDI.OL — annual report dated 2023-12-31
Total revenue: 51189489.194499016
Gross profit: 40160019.64636543
Operating income: 12910314.341846758
Net income: 10198722.986247545
Capital expenditures: 1610903.7328094302
Operating cash flow: 11709037.328094304
Depreciation & amortization: 2325147.347740668
Net tangible assets: 34633300.58939096
Owner earnings: 10912966.601178782
Return on net tangible assets (%): 31.510039226586716
Capex to operating income (%): 12.477649189283785
Buffett classification: The Great
Stock price: 19.077603143418468
P/E ratio: 34.19966587442089
Shares outstanding: 18282848
Book value: 39090471.51277014
P/B ratio: 8.922709421949484
Market cap (USD): 348792918.47544205
Debt to equity: 0.044338231044300534
Current ratio: 4.153048237240677
Quick ratio: 2.610994442323194
Effective tax rate (%): 23.214655503949356
Interest coverage ratio: 229.36649214659684
COGS to revenue (%): 21.546355944725576
SG&A to revenue (%): 9.956458245779675
Free cash flow (dilution-adjusted): 8788998.035363458
Buyback yield (%): 0
Retained earnings: 30194499.01768173
Inventory turnover: 0.7722623821281922
Receivables turnover: 7.013296905912278
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.94364102140319
FCF margin (%): 17.169536507717197
Revenue growth (%): 4.0081588200703155
Rule of 40 score: 21.17769532778751
Financial ratios for MEDI.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.849236641221372
Shares outstanding: 18282848
Market cap (USD): 289769184.4274809
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDI.OL — quarterly report dated 2024-12-31
Total revenue: 13339717.563989408
Gross profit: 10375375.110326566
Operating income: 2281023.8305383935
Net income: 1880141.2180052956
Capital expenditures: 0
Operating cash flow: 5641218.005295675
Depreciation & amortization: 577405.1191526919
Net tangible assets: 33176787.290379524
Owner earnings: 2457546.3371579875
Return on net tangible assets (%): 7.407427113566892
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.268077601410935
P/E ratio: 29.82427541756187
Shares outstanding: 18282848
Book value: 38535745.80759047
P/B ratio: 5.8204504243595245
Market cap (USD): 224295398.03880072
Debt to equity: 0.07870639701335287
Current ratio: 3.9968612329672992
Quick ratio: 2.501792915886632
Effective tax rate (%): 24.727915194346288
Interest coverage ratio: 55.34047109207709
COGS to revenue (%): 22.221928158847152
Free cash flow (dilution-adjusted): 5641218.005295675
Buyback yield (%): 0
Retained earnings: 29020123.565754633
Inventory turnover: 0.20923119093451947
Receivables turnover: 2.1910553783705424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.526934287993394
FCF margin (%): 42.288886389350196
Rule of 40 score: 42.288886389350196
Financial ratios for MEDI.OL — annual report dated 2024-12-31
Total revenue: 49655692.85083848
Gross profit: 39622153.57458076
Operating income: 11568843.777581641
Net income: 9164342.453662843
Capital expenditures: 535569.2850838482
Operating cash flow: 12630538.39364519
Depreciation & amortization: 2163283.3186231246
Net tangible assets: 33176787.290379524
Owner earnings: 10792056.48720212
Return on net tangible assets (%): 32.52893775622318
Capex to operating income (%): 4.629410642761778
Buffett classification: The Great
Stock price: 12.268077601410935
P/E ratio: 24.47479447356896
Shares outstanding: 18282848
Book value: 38535745.80759047
P/B ratio: 5.8204504243595245
Market cap (USD): 224295398.03880072
Debt to equity: 0.07870639701335287
Current ratio: 3.9968612329672992
Quick ratio: 2.501792915886632
Effective tax rate (%): 22.655423625284925
Interest coverage ratio: 285.5664488017429
COGS to revenue (%): 20.206221482796806
SG&A to revenue (%): 10.763972207558135
Free cash flow (dilution-adjusted): 10451103.265666373
Buyback yield (%): 0
Retained earnings: 29020123.565754633
Inventory turnover: 0.7081939434715707
Receivables turnover: 8.155972745723398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.03137717840637
FCF margin (%): 21.047140147778435
Revenue growth (%): -2.996311093929337
Rule of 40 score: 18.0508290538491
Financial ratios for MEDI.OL — quarterly report dated 2025-03-31
Total revenue: 17323187.022900764
Gross profit: 14406679.389312977
Operating income: 5646087.786259542
Net income: 4143606.8702290077
Capital expenditures: 0
Operating cash flow: 1795896.9465648853
Depreciation & amortization: 531679.3893129771
Net tangible assets: 37325477.09923664
Owner earnings: 4675286.259541985
Return on net tangible assets (%): 12.525724043960315
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.450381679389311
P/E ratio: 17.042940403914795
Shares outstanding: 18282848
Book value: 44505916.03053435
P/B ratio: 6.3469535059667
Market cap (USD): 282476979.78625953
Debt to equity: 0.056112276007563966
Current ratio: 3.912090654952076
Quick ratio: 2.5153587593184232
Effective tax rate (%): 23.426203491447716
Interest coverage ratio: 17.251020408163267
COGS to revenue (%): 16.835860686213486
Free cash flow (dilution-adjusted): 1795896.9465648853
Buyback yield (%): 0.2675013629656211
Inventory turnover: 0.1820689080035264
Receivables turnover: 1.9670296332412374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.902616238136812
FCF margin (%): 10.367012398993097
Revenue growth (%): 29.86172263245467
Rule of 40 score: 40.22873503144777
Financial ratios for MEDI.OL — quarterly report dated 2025-06-30
Total revenue: 16790069.513406157
Gross profit: 13747567.030784508
Operating income: 5375968.2224429
Net income: 4268520.357497517
Capital expenditures: 0
Operating cash flow: 3739126.1171797416
Depreciation & amortization: 849553.1281032771
Net tangible assets: 30508937.43793446
Owner earnings: 5118073.485600794
Return on net tangible assets (%): 16.77565302302872
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.026812313803376
P/E ratio: 35.574972357977686
Shares outstanding: 18282848
Book value: 38113803.37636544
P/B ratio: 9.606681386325384
Market cap (USD): 366147165.45779544
Debt to equity: 0.05740660646263999
Current ratio: 3.136062063113661
Quick ratio: 1.7271889773324174
Effective tax rate (%): 23.715548298933392
COGS to revenue (%): 18.12084506375831
Free cash flow (dilution-adjusted): 3739126.1171797416
Buyback yield (%): 0.12619667303276721
Inventory turnover: 0.17573605749651544
Receivables turnover: 1.7963685043720319
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.162424749326512
FCF margin (%): 22.269866805460264
Revenue growth (%): -3.0774793852299815
Rule of 40 score: 19.192387420230283
Financial ratios for MEDI.OL — quarterly report dated 2025-12-31
Total revenue: 18138805.970149253
Gross profit: 14543781.094527362
Operating income: 4211442.786069651
Net income: 3789850.7462686566
Capital expenditures: 0
Operating cash flow: 6568059.701492537
Depreciation & amortization: 698706.4676616915
Net tangible assets: 38040597.01492537
Owner earnings: 4488557.213930348
Return on net tangible assets (%): 11.799386881781182
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.89143426294821
P/E ratio: 32.31660682079666
Shares outstanding: 18282848
Book value: 46607562.18905473
P/B ratio: 9.764216100501093
Market cap (USD): 455086309.13147414
Debt to equity: 0.10518866111877302
Current ratio: 3.3358308486198496
Quick ratio: 2.210678099840094
Effective tax rate (%): 20.392935520953078
COGS to revenue (%): 19.819523300145367
Free cash flow (dilution-adjusted): 6568059.701492537
Buyback yield (%): 0
Retained earnings: 36698208.95522388
Inventory turnover: 0.22422610034009383
Receivables turnover: 2.1101889151271007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.180451185947986
FCF margin (%): 36.209989303052744
Revenue growth (%): 8.032941469755002
Rule of 40 score: 44.242930772807746
Financial ratios for MEDI.OL — annual report dated 2025-12-31
Total revenue: 69628557.21393034
Gross profit: 56874925.37313432
Operating income: 19522089.552238803
Net income: 15841791.044776117
Capital expenditures: 1544875.6218905472
Operating cash flow: 18615323.383084577
Depreciation & amortization: 2470447.76119403
Net tangible assets: 38040597.01492537
Owner earnings: 16767363.1840796
Return on net tangible assets (%): 44.07755003818911
Capex to operating income (%): 7.9134747218357075
Buffett classification: The Great
Stock price: 24.89143426294821
P/E ratio: 28.72694809855735
Shares outstanding: 18282848
Book value: 46607562.18905473
P/B ratio: 9.764216100501093
Market cap (USD): 455086309.13147414
Debt to equity: 0.10518866111877302
Current ratio: 3.3358308486198496
Quick ratio: 2.210678099840094
Effective tax rate (%): 23.03080991447868
Interest coverage ratio: 31.49229534510433
COGS to revenue (%): 18.31666826243593
SG&A to revenue (%): 8.911680602257608
Free cash flow (dilution-adjusted): 15330746.268656716
Buyback yield (%): 0.10175752770902255
Retained earnings: 36698208.95522388
Inventory turnover: 0.7954596231660999
Receivables turnover: 8.100280131499744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.920377586046946
FCF margin (%): 22.01790024393834
Revenue growth (%): 40.222708044954
Rule of 40 score: 62.24060828889233
Financial ratios for MEGASTAR.NS — annual report dated 2022-03-31
Total revenue: 24369378.87379665
Gross profit: 3089225.900039562
Operating income: 1291269.9459316893
Net income: 719082.1574574707
Capital expenditures: 903138.599498879
Operating cash flow: 3614506.1321376762
Depreciation & amortization: 244547.01305551894
Net tangible assets: 4730093.6304892525
Owner earnings: 60490.57101411058
Return on net tangible assets (%): 1.2788451083547325
Capex to operating income (%): 69.9418895595249
Buffett classification: The Good
Stock price: 1.6767770011868655
P/E ratio: 26.33498303623826
Shares outstanding: 11293700
Book value: 4730093.630489253
P/B ratio: 4.003518301675853
Market cap (USD): 18937016.4183041
Debt to equity: 0.9569369052896288
Current ratio: 1.3075770919831526
Quick ratio: 0.5798209824397432
Effective tax rate (%): 24.420635360647562
Interest coverage ratio: 3.346445659603554
COGS to revenue (%): 87.32332934689086
SG&A to revenue (%): 0.9046338335326556
Free cash flow (dilution-adjusted): 2400632.994856917
Buyback yield (%): 0
Retained earnings: 2705842.015033628
Inventory turnover: 6.642246471365475
Receivables turnover: 10.775290529863495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.64739380444416
FCF margin (%): 9.851022495440844
Rule of 40 score: 9.851022495440844
Financial ratios for MEGASTAR.NS — annual report dated 2023-03-31
Total revenue: 37052606.5773447
Gross profit: 4398526.187576127
Operating income: 2399890.377588307
Net income: 1228014.616321559
Capital expenditures: 3368112.0584652866
Operating cash flow: 1405822.168087698
Depreciation & amortization: 262436.0535931791
Net tangible assets: 5613410.475030451
Owner earnings: -1877661.3885505483
Return on net tangible assets (%): -33.449565053237315
Capex to operating income (%): 140.3444128081368
Buffett classification: The Gruesome
Stock price: 2.618757612667479
P/E ratio: 24.083966474905775
Shares outstanding: 11293700
Book value: 5613410.475030451
P/B ratio: 5.268715512920382
Market cap (USD): 29575462.85018271
Debt to equity: 1.2547015260566634
Current ratio: 1.489962036167694
Quick ratio: 0.8520934536201711
Effective tax rate (%): 26.006928135274777
Interest coverage ratio: 3.4311014366565082
COGS to revenue (%): 88.1289696086711
SG&A to revenue (%): 0.8684035175322707
Free cash flow (dilution-adjusted): -2029354.4457978078
Buyback yield (%): 0
Retained earnings: 3743751.522533496
Inventory turnover: 11.43787224601942
Receivables turnover: 11.566524208941376
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.662958798001
FCF margin (%): -5.476954614681895
Revenue growth (%): 52.0457569691519
Rule of 40 score: 46.56880235447001
Financial ratios for MEGASTAR.NS — annual report dated 2024-03-31
Total revenue: 32965091.73761842
Gross profit: 3395754.8866770593
Operating income: 1255042.571051685
Net income: 758184.4345844826
Capital expenditures: 6211128.432665788
Operating cash flow: 1946360.4748770837
Depreciation & amortization: 308682.0961746013
Net tangible assets: 11047559.659431586
Owner earnings: -5144261.901906704
Return on net tangible assets (%): -46.56468994503157
Capex to operating income (%): 494.8938447132565
Buffett classification: The Gruesome
Stock price: 3.1711852207293667
P/E ratio: 47.2370743762091
Shares outstanding: 11293700
Book value: 11047559.659431588
P/B ratio: 3.2418394316409556
Market cap (USD): 35814414.527351245
Debt to equity: 0.6171324800055575
Current ratio: 2.2238485913569233
Quick ratio: 1.453925442989565
Effective tax rate (%): 23.051177508671575
Interest coverage ratio: 2.6554856388917085
COGS to revenue (%): 89.69893694303917
SG&A to revenue (%): 0.6933897522662216
Free cash flow (dilution-adjusted): -4264767.957788704
Buyback yield (%): 0
Retained earnings: 4443062.7173522
Inventory turnover: 14.581051274621695
Receivables turnover: 10.13329032733707
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.835706076793782
FCF margin (%): -12.937224600294147
Revenue growth (%): -11.031652607742675
Rule of 40 score: -23.968877208036822
Financial ratios for MEGASTAR.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 10964727.663640708
Buffett classification: The Gruesome
Stock price: 3.3635929288103203
Shares outstanding: 11293700
Book value: 10964727.663640708
P/B ratio: 3.4645100749809092
Market cap (USD): 37987409.46010511
Debt to equity: 1.9482334332279918
Current ratio: 1.0251017036471193
Quick ratio: 0.3027641461641139
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEGASTAR.NS — quarterly report dated 2024-12-31
Total revenue: 10805548.432218207
Gross profit: 1437836.5776897073
Operating income: 512192.56323580834
Net income: 52010.72386058981
Capital expenditures: 0
Depreciation & amortization: 176372.5375917939
Owner earnings: 228383.2614523837
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6104441077048604
P/E ratio: 141.70910550201702
Shares outstanding: 11293700
Market cap (USD): 29481572.619186383
Effective tax rate (%): 100.06599571027883
Interest coverage ratio: 1.1288631984585742
COGS to revenue (%): 86.69353446787946
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEGASTAR.NS — quarterly report dated 2025-03-31
Total revenue: 14190250.175356558
Gross profit: 2255319.14893617
Operating income: 882791.6764086976
Net income: 153553.89291559503
Capital expenditures: 0
Depreciation & amortization: 251356.09071779283
Net tangible assets: 10950631.283610007
Owner earnings: 404909.98363338783
Return on net tangible assets (%): 3.6975948979254136
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2729606721904543
P/E ratio: 41.79336559970447
Shares outstanding: 11293700
Book value: 10950631.283610007
P/B ratio: 2.344169507555081
Market cap (USD): 25670135.943517335
Debt to equity: 1.405649731989491
Current ratio: 1.142217515253244
Quick ratio: 0.6270415367809663
Effective tax rate (%): 32.63066112735293
Interest coverage ratio: 1.3448380260369361
COGS to revenue (%): 84.10655822789607
Buyback yield (%): 0
Retained earnings: 4782452.653729249
Inventory turnover: 2.6399170463537116
Receivables turnover: 2.9382401068949155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.687663921425728
Revenue growth (%): 31.32373858087946
Rule of 40 score: 31.32373858087946
Financial ratios for MEGASTAR.NS — annual report dated 2025-03-31
Total revenue: 42203553.89291559
Gross profit: 5653074.584989478
Operating income: 1951624.970773907
Net income: 443383.2125321487
Capital expenditures: 5872410.568155249
Operating cash flow: -1153285.012859481
Depreciation & amortization: 626209.9602525134
Net tangible assets: 10950631.283610007
Owner earnings: -4802817.395370587
Return on net tangible assets (%): -43.85881755108533
Capex to operating income (%): 300.89851565214263
Buffett classification: The Gruesome
Stock price: 2.2729606721904543
P/E ratio: 57.89604842482856
Shares outstanding: 11293700
Book value: 10950631.283610007
P/B ratio: 2.344169507555081
Market cap (USD): 25670135.943517335
Debt to equity: 1.405649731989491
Current ratio: 1.142217515253244
Quick ratio: 0.6270415367809663
Effective tax rate (%): 27.872125972272404
Interest coverage ratio: 1.430216320411223
COGS to revenue (%): 86.60521670915865
SG&A to revenue (%): 0.5673539621704932
Free cash flow (dilution-adjusted): -7025695.581014729
Buyback yield (%): 1.0530445981557541
Retained earnings: 4782452.653729249
Inventory turnover: 8.084691328654692
Receivables turnover: 8.738688407130201
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.363217289120612
FCF margin (%): -16.647165778600655
Revenue growth (%): 28.024985426491668
Rule of 40 score: 11.377819647891013
Financial ratios for MEGASTAR.NS — quarterly report dated 2025-06-30
Total revenue: 12559770.652937047
Gross profit: 1716861.6896793824
Operating income: 537912.4736718934
Net income: 189035.80622513458
Capital expenditures: 0
Depreciation & amortization: 255604.9613854435
Owner earnings: 444640.7676105781
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.3038848584132934
P/E ratio: 94.55915972329672
Shares outstanding: 11293700
Market cap (USD): 37313084.42546221
Effective tax rate (%): 23.95499905855771
Interest coverage ratio: 1.8427804056762611
COGS to revenue (%): 86.3304694239946
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -11.490139372250647
Rule of 40 score: -11.490139372250647
Financial ratios for MEGASTAR.NS — quarterly report dated 2025-09-30
Total revenue: 15554114.994363021
Gross profit: 2077046.2232243516
Operating income: 779718.1510710259
Net income: 268038.3314543405
Capital expenditures: 0
Depreciation & amortization: 252694.4757609921
Net tangible assets: 11038466.741826382
Owner earnings: 520732.8072153326
Return on net tangible assets (%): 4.7174378416360945
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.508117249154453
P/E ratio: 42.74715836692141
Shares outstanding: 11293700
Book value: 11038466.741826385
P/B ratio: 2.5661103520332698
Market cap (USD): 28325923.776775647
Debt to equity: 1.7767466847510798
Current ratio: 1.0571983071750772
Quick ratio: 0.3299071015863898
Effective tax rate (%): 31.927503865315238
Interest coverage ratio: 1.9471550437793856
COGS to revenue (%): 86.64632334287681
Buyback yield (%): 0
Inventory turnover: 0.8677708807749293
Receivables turnover: 3.063132070025866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.152210287558618
Revenue growth (%): 23.840756524688288
Rule of 40 score: 23.840756524688288
Financial ratios for MEGASTAR.NS — quarterly report dated 2025-12-31
Total revenue: 15730589.283725075
Gross profit: 1969722.6244847944
Operating income: 797727.5258995211
Net income: 341149.6045449482
Capital expenditures: 0
Depreciation & amortization: 257034.6440904534
Owner earnings: 598184.2486354016
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.559763840926813
P/E ratio: 30.37390649132268
Shares outstanding: 11293700
Market cap (USD): 28909204.890275147
Effective tax rate (%): 17.68579492003763
Interest coverage ratio: 1.9852517187846532
COGS to revenue (%): 87.47839264659541
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.134582645338616
Rule of 40 score: 1.134582645338616
Financial ratios for MFAI.L — annual report dated 2021-12-31
Total revenue: 0
Operating income: -797297.2972972973
Net income: 2014864.8648648649
Capital expenditures: 0
Operating cash flow: -736486.4864864865
Net tangible assets: 9760810.810810812
Owner earnings: 2014864.8648648649
Return on net tangible assets (%): 20.642392357746086
Buffett classification: The Gruesome
Stock price: 0.001081081081081081
P/E ratio: 0.28258194822266935
Shares outstanding: 526662106
Book value: 9760810.81081081
P/B ratio: 0.058331674484286306
Market cap (USD): 569364.438918919
Debt to equity: 0
Current ratio: 42.27428571428572
Quick ratio: 42.27428571428572
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -736486.4864864865
Buyback yield (%): 0
Retained earnings: -17624324.324324325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.1683511006507
Rule of 40 score: 0
Financial ratios for MFAI.L — annual report dated 2022-12-31
Total revenue: 16867.469879518074
Operating income: -930120.4819277109
Net income: -440963.8554216868
Capital expenditures: 0
Operating cash flow: -1245783.1325301204
Net tangible assets: 9424096.38554217
Owner earnings: -440963.8554216868
Return on net tangible assets (%): -4.679110201994375
Buffett classification: The Gruesome
Stock price: 0.00024096385542168676
Shares outstanding: 526662106
Book value: 9424096.38554217
P/B ratio: 0.01346617504474559
Market cap (USD): 126906.53156626507
Debt to equity: 0.15788800818205062
Current ratio: 32.01712328767123
Quick ratio: 32.01712328767123
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1245783.1325301204
Buyback yield (%): 0
Retained earnings: -16154216.86746988
Receivables turnover: 0.03753351206434317
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.523793750690075
FCF margin (%): -7385.714285714284
Rule of 40 score: -7385.714285714284
Financial ratios for MFAI.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -3378481.0126582277
Net income: -3373417.7215189873
Capital expenditures: 0
Operating cash flow: -887341.7721518987
Net tangible assets: 7397468.354430379
Owner earnings: -3373417.7215189873
Return on net tangible assets (%): -45.602327173169066
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 526662106
Book value: 7397468.354430379
P/B ratio: 0.00901201413415469
Market cap (USD): 66666.08936708861
Debt to equity: 0.22758384668035592
Current ratio: 4.772756617172369
Quick ratio: 4.772756617172369
Free cash flow (dilution-adjusted): -887341.7721518987
Buyback yield (%): 0
Retained earnings: -20345569.620253164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -45.67077344284737
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for MFAI.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13491250
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 526662106
Book value: 13491250
P/B ratio: 0.0048796637264893914
Market cap (USD): 65832.76325
Debt to equity: 0.08199759103122393
Current ratio: 18.60062893081761
Quick ratio: 18.60062893081761
Buyback yield (%): 0
Retained earnings: -16142500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MFAI.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -472500
Net income: 3948750
Capital expenditures: 0
Operating cash flow: -665000
Net tangible assets: 13491250
Owner earnings: 3948750
Return on net tangible assets (%): 29.26897062911146
Buffett classification: The Gruesome
Stock price: 0.000125
P/E ratio: 0.016671798227287114
Shares outstanding: 526662106
Book value: 13491250
P/B ratio: 0.0048796637264893914
Market cap (USD): 65832.76325
Debt to equity: 0.08199759103122393
Current ratio: 18.60062893081761
Quick ratio: 18.60062893081761
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -665000
Buyback yield (%): 0
Retained earnings: -16142500
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.376809004824013
Rule of 40 score: 0
Financial ratios for MFAI.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00013698630136986303
Shares outstanding: 526662106
Market cap (USD): 72145.49397260275
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLIRF.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.034090909090909
Shares outstanding: 9094431
Market cap (USD): 18498899.420454547
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLIRF.PA — annual report dated 2022-12-31
Total revenue: 126476.59574468086
Gross profit: 118346.80851063831
Operating income: -2116802.1276595746
Net income: 2053956.3829787236
Capital expenditures: 0
Operating cash flow: -419674.4680851064
Depreciation & amortization: 6490.425531914894
Net tangible assets: 16600190.425531916
Owner earnings: 2060446.8085106385
Return on net tangible assets (%): 12.412187786361589
Buffett classification: The Gruesome
Stock price: 1.8085106382978724
P/E ratio: 8.007655541795568
Shares outstanding: 9094431
Book value: 16613441.489361703
P/B ratio: 0.9900041013957231
Market cap (USD): 16447375.212765958
Debt to equity: 0.11814971663229626
Current ratio: 92.70432238900372
Quick ratio: 92.70432238900372
Interest coverage ratio: -19.356914246801885
COGS to revenue (%): 6.427898526344123
SG&A to revenue (%): 137.00962250185046
Free cash flow (dilution-adjusted): -421627.6595744681
Buyback yield (%): 10.495964346687742
Retained earnings: 2053956.3829787236
Receivables turnover: 5.612955006845758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.39506793308948
FCF margin (%): -333.3641746854182
Rule of 40 score: -333.3641746854182
Financial ratios for MLIRF.PA — annual report dated 2023-12-31
Total revenue: 145358.88888888888
Gross profit: 43700
Operating income: -916395.5555555555
Net income: -934707.7777777778
Capital expenditures: 0
Operating cash flow: -507554.44444444444
Depreciation & amortization: 6690
Net tangible assets: 16299376.666666666
Owner earnings: -928017.7777777778
Return on net tangible assets (%): -5.693578329750715
Buffett classification: The Gruesome
Stock price: 1.7555555555555555
Shares outstanding: 9094431
Book value: 16314598.88888889
P/B ratio: 0.9786191481262964
Market cap (USD): 15965778.866666667
Debt to equity: 0.12395857588762184
Current ratio: 9.227480082471857
Quick ratio: 9.227480082471857
Interest coverage ratio: -7.886062877686835
COGS to revenue (%): 69.93647905949261
SG&A to revenue (%): 92.32550851150029
Free cash flow (dilution-adjusted): -515626.6666666666
Buyback yield (%): 0.6420607529145994
Retained earnings: -934707.7777777778
Receivables turnover: 2.445152608264957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.9959302923932105
FCF margin (%): -354.72661535051174
Revenue growth (%): 14.929476108232567
Rule of 40 score: -339.7971392422792
Financial ratios for MLIRF.PA — annual report dated 2024-12-31
Total revenue: 266018.75
Gross profit: 162234.375
Operating income: -928001.0416666667
Net income: 1212044.7916666667
Capital expenditures: 4085.416666666667
Operating cash flow: 503917.7083333334
Depreciation & amortization: 6540.625
Net tangible assets: 13866686.458333334
Owner earnings: 1214500
Return on net tangible assets (%): 8.758400960815935
Buffett classification: The Gruesome
Stock price: 1.25
P/E ratio: 9.379223299468958
Shares outstanding: 9094431
Book value: 13874825
P/B ratio: 0.8193284419803493
Market cap (USD): 11368038.75
Debt to equity: 0.13665442627204308
Current ratio: 4.881095751520847
Quick ratio: 4.881095751520847
Interest coverage ratio: -8.551280943742142
COGS to revenue (%): 39.01393228860748
SG&A to revenue (%): 57.732850911198305
Free cash flow (dilution-adjusted): 499832.2916666667
Buyback yield (%): 23.154032396309347
Retained earnings: 1212044.7916666667
Receivables turnover: 4.520604687389365
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.8779273150976685
FCF margin (%): 187.89363218444817
Revenue growth (%): 83.0082439632175
Rule of 40 score: 270.9018761476657
Financial ratios for MMM.V — annual report dated 2021-12-31
Capital expenditures: 671.6535433070866
Buffett classification: The Gruesome
Stock price: 0.05511811023622048
Shares outstanding: 43175881
Market cap (USD): 2379772.968503937
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMM.V — annual report dated 2022-12-31
Total revenue: 329989.7058823529
Gross profit: 259958.82352941175
Operating income: -1883046.3235294116
Net income: -1890971.3235294116
Capital expenditures: 0
Operating cash flow: 493979.41176470584
Depreciation & amortization: 32472.05882352941
Net tangible assets: 5074832.352941176
Owner earnings: -1858499.2647058822
Return on net tangible assets (%): -36.62188493042077
Buffett classification: The Gruesome
Stock price: 0.03676470588235294
Shares outstanding: 43175881
Book value: 5074832.352941176
P/B ratio: 0.31278837521726305
Market cap (USD): 1587348.5661764706
Debt to equity: 0.030731238296483863
Current ratio: 88.02972942174502
Quick ratio: 88.02972942174502
Interest coverage ratio: -144.07555555555555
COGS to revenue (%): 21.222141510653188
SG&A to revenue (%): 40.12647453351932
Free cash flow (dilution-adjusted): 493979.41176470584
Buyback yield (%): 6.257938315144049
Retained earnings: -29821408.82352941
Receivables turnover: 16.018346004211725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.163869894157955
FCF margin (%): 149.69540048040716
Rule of 40 score: 149.69540048040716
Financial ratios for MMM.V — annual report dated 2023-12-31
Total revenue: 152136.36363636362
Gross profit: 75711.36363636363
Operating income: -1047033.3333333333
Net income: -1063478.0303030303
Capital expenditures: 0
Operating cash flow: -278040.90909090906
Depreciation & amortization: 29762.121212121212
Net tangible assets: 4170379.5454545454
Owner earnings: -1033715.9090909091
Return on net tangible assets (%): -24.787094263820546
Buffett classification: The Gruesome
Stock price: 0.03787878787878788
Shares outstanding: 43175881
Book value: 4170379.545454545
P/B ratio: 0.39215856016302575
Market cap (USD): 1635450.0378787878
Debt to equity: 0.03327743768689028
Current ratio: 66.45494613124387
Quick ratio: 66.45494613124387
Interest coverage ratio: -87.39623118755533
COGS to revenue (%): 50.23453839259039
SG&A to revenue (%): 130.99492082461907
Free cash flow (dilution-adjusted): -340857.57575757575
Buyback yield (%): 3.5203913962983178
Retained earnings: -31106290.15151515
Receivables turnover: 101.83569979716025
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.453410149883926
FCF margin (%): -224.04740563688875
Revenue growth (%): -53.89663346328661
Rule of 40 score: -277.94403910017536
Financial ratios for MMM.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.037037037037037035
Shares outstanding: 43175881
Market cap (USD): 1599106.7037037036
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMM.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 43175881
Market cap (USD): 1509646.188811189
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMM.V — annual report dated 2024-12-31
Total revenue: -664460.8391608392
Gross profit: -732639.8601398602
Operating income: -268951.7482517483
Net income: -280759.4405594406
Capital expenditures: 0
Operating cash flow: -83755.94405594406
Depreciation & amortization: 25609.09090909091
Net tangible assets: 3584141.958041958
Owner earnings: -255150.34965034967
Return on net tangible assets (%): -7.118868410829913
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 43175881
Book value: 3584141.9580419585
P/B ratio: 0.4212015613454996
Market cap (USD): 1509646.188811189
Debt to equity: 0.02855429794375886
Current ratio: 67.06161223431829
Quick ratio: 67.06161223431829
Interest coverage ratio: -29.539247311827957
Free cash flow (dilution-adjusted): -105817.48251748251
Buyback yield (%): 0.4465456072569775
Retained earnings: -28897993.706293706
Receivables turnover: -125.86819446284277
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.350970264389592
Revenue growth (%): -536.7534646411253
Rule of 40 score: -536.7534646411253
Financial ratios for MMM.V — quarterly report dated 2025-03-31
Total revenue: 439426.5734265734
Gross profit: 422211.18881118885
Operating income: 142797.2027972028
Net income: 133551.04895104896
Capital expenditures: 0
Operating cash flow: 597406.2937062937
Depreciation & amortization: 6386.713286713287
Net tangible assets: 3717693.0069930074
Owner earnings: 139937.76223776225
Return on net tangible assets (%): 3.764102145457904
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.03496503496503497
P/E ratio: 2.8259721669511673
Shares outstanding: 43175881
Book value: 3717693.006993007
P/B ratio: 0.4060706965237672
Market cap (USD): 1509646.188811189
Debt to equity: 0.025606526041320837
Current ratio: 64.81632160318706
Quick ratio: 64.81632160318706
Interest coverage ratio: 73.61211247296323
COGS to revenue (%): 3.9176931156306694
SG&A to revenue (%): 5.862535408510774
Free cash flow (dilution-adjusted): 597406.2937062937
Buyback yield (%): 0
Retained earnings: -28764442.657342657
Receivables turnover: 46.39545186060248
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7732676368386966
FCF margin (%): 135.95133517935008
Rule of 40 score: 135.95133517935008
Financial ratios for MMM.V — quarterly report dated 2025-06-30
Total revenue: 30953.284671532845
Gross profit: 15540.14598540146
Operating income: 502262.7737226277
Net income: 478478.10218978097
Capital expenditures: 0
Operating cash flow: -670778.8321167883
Depreciation & amortization: 6667.153284671533
Net tangible assets: 4364643.065693431
Owner earnings: 485145.2554744525
Return on net tangible assets (%): 11.115347765496496
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.0364963503649635
P/E ratio: 2.5746520036745486
Shares outstanding: 43175881
Book value: 4364643.065693431
P/B ratio: 0.36102885312149163
Market cap (USD): 1575762.0802919706
Debt to equity: 0.02147281380689987
Current ratio: 86.71434539587413
Quick ratio: 86.71434539587413
Interest coverage ratio: 262.63358778625957
COGS to revenue (%): 49.79484035278027
SG&A to revenue (%): 110.40418808659152
Free cash flow (dilution-adjusted): -676432.1167883211
Buyback yield (%): 0
Retained earnings: -29545721.16788321
Receivables turnover: 5.721262817053427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.342914725216614
FCF margin (%): -2185.332264302221
Revenue growth (%): -92.95598251371909
Rule of 40 score: -2278.28824681594
Financial ratios for MMM.V — quarterly report dated 2025-09-30
Total revenue: 126680.57553956835
Gross profit: 114244.60431654677
Operating income: 618057.5539568346
Net income: 614579.1366906476
Capital expenditures: 0
Operating cash flow: 160885.61151079138
Depreciation & amortization: 6570.503597122302
Net tangible assets: 4926779.856115108
Owner earnings: 621149.6402877698
Return on net tangible assets (%): 12.60761914329905
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.04316546762589928
P/E ratio: 1.5193987453158584
Shares outstanding: 43175881
Book value: 4926779.856115108
P/B ratio: 0.3782809762063858
Market cap (USD): 1863707.09352518
Debt to equity: 0.01717730027522464
Current ratio: 89.32392121290657
Quick ratio: 89.32392121290657
Interest coverage ratio: 356.62100456621005
COGS to revenue (%): 9.81679406653567
SG&A to revenue (%): 37.912156559862794
Free cash flow (dilution-adjusted): 142093.52517985614
Buyback yield (%): 0.4525288860540758
Retained earnings: -28395360.431654677
Receivables turnover: 104.13128326434062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.408965770262972
FCF margin (%): 112.16678214054497
Revenue growth (%): 309.2637562826219
Rule of 40 score: 421.43053842316687
Financial ratios for MMM.V — annual report dated 2025-12-31
Total revenue: 709835.0364963503
Gross profit: 641688.3211678831
Operating income: 3469559.8540145983
Net income: 3425026.2773722624
Capital expenditures: 0
Operating cash flow: 206695.62043795618
Depreciation & amortization: 27124.087591240874
Net tangible assets: 7196629.197080292
Owner earnings: 3452150.364963503
Return on net tangible assets (%): 47.96899034848228
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.0656934306569343
P/E ratio: 0.8281313820172086
Shares outstanding: 43175881
Book value: 7196629.197080292
P/B ratio: 0.394125036437375
Market cap (USD): 2836371.744525547
Debt to equity: 0.011046838432672556
Current ratio: 94.62446750721902
Quick ratio: 94.62446750721902
Interest coverage ratio: 467.47610149488594
COGS to revenue (%): 9.600359495472373
SG&A to revenue (%): 21.66268712582547
Free cash flow (dilution-adjusted): 165137.22627737225
Buyback yield (%): 0.390186981168182
Retained earnings: -26595574.452554744
Receivables turnover: 879.2712477396022
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 47.89843505950401
FCF margin (%): 23.264169530496446
Rule of 40 score: 23.264169530496446
Financial ratios for MMM.V — quarterly report dated 2025-12-31
Total revenue: 91680.29197080291
Gross profit: 69533.57664233576
Operating income: 2191165.6934306566
Net income: 2183597.0802919706
Capital expenditures: 0
Operating cash flow: 90670.07299270072
Depreciation & amortization: 7124.087591240876
Net tangible assets: 7196629.197080292
Owner earnings: 2190721.1678832113
Return on net tangible assets (%): 30.440934330366748
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.0656934306569343
P/E ratio: 0.8317304790609524
Shares outstanding: 43175881
Book value: 7196629.197080292
P/B ratio: 0.394125036437375
Market cap (USD): 2836371.744525547
Debt to equity: 0.011046838432672556
Current ratio: 94.62446750721902
Quick ratio: 94.62446750721902
Interest coverage ratio: 1269.3010570824524
COGS to revenue (%): 24.156462476712157
SG&A to revenue (%): 47.96818521998058
Free cash flow (dilution-adjusted): 73831.38686131386
Buyback yield (%): 0.08850105713213151
Retained earnings: -26595574.452554744
Receivables turnover: 113.56419529837251
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.249775789272142
FCF margin (%): 80.53136096558973
Revenue growth (%): -27.62876898821256
Rule of 40 score: 52.90259197737717
Financial ratios for MNTK — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 22869000
Buffett classification: The Gruesome
Stock price: 10.25
Shares outstanding: 142341139
Market cap (USD): 1458996674.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MNTK — annual report dated 2022-12-31
Total revenue: 205559000
Gross profit: 104129000
Operating income: 49290000
Net income: 35194000
Capital expenditures: 22277000
Operating cash flow: 81066000
Depreciation & amortization: 20700000
Net tangible assets: 211336000
Owner earnings: 33617000
Return on net tangible assets (%): 15.906897073853957
Capex to operating income (%): 45.195780077094746
Buffett classification: The Good
Stock price: 11.03
P/E ratio: 44.610523474740006
Shares outstanding: 142341139
Book value: 227091000
P/B ratio: 6.913628295132788
Market cap (USD): 1570022763.1699998
Debt to equity: 0.3356451818874372
Current ratio: 4.396450954158158
Quick ratio: 4.396450954158158
Effective tax rate (%): 18.611535081633594
Interest coverage ratio: 27.505580357142858
COGS to revenue (%): 49.3434974873394
SG&A to revenue (%): 16.607883867891942
Free cash flow (dilution-adjusted): 48953000
Buyback yield (%): 0.015159015880728967
Retained earnings: 30666000
Receivables turnover: 12.671618789298483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.218403890574308
FCF margin (%): 23.81457391795056
Rule of 40 score: 23.81457391795056
Financial ratios for MNTK — annual report dated 2023-12-31
Total revenue: 174904000
Gross profit: 80281000
Operating income: 24720000
Net income: 14948000
Capital expenditures: 63091000
Operating cash flow: 41053000
Depreciation & amortization: 21158000
Net tangible assets: 231818000
Owner earnings: -26985000
Return on net tangible assets (%): -11.640597365174404
Capex to operating income (%): 255.2224919093851
Buffett classification: The Gruesome
Stock price: 8.91
P/E ratio: 84.8447650849612
Shares outstanding: 142341139
Book value: 250239000
P/B ratio: 5.068193001450613
Market cap (USD): 1268259548.49
Debt to equity: 0.2720958763422168
Current ratio: 3.0724020442930153
Quick ratio: 3.0724020442930153
Effective tax rate (%): 18.610475879342264
Interest coverage ratio: 4.296888579871371
COGS to revenue (%): 54.099963408498375
SG&A to revenue (%): 19.669647349403103
Free cash flow (dilution-adjusted): -30356000
Buyback yield (%): 0.009619482080403351
Retained earnings: 45614000
Receivables turnover: 13.715809284818068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.703622447707612
FCF margin (%): -17.35580661391392
Revenue growth (%): -14.912993349841164
Rule of 40 score: -32.268799963755086
Financial ratios for MNTK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.21
Shares outstanding: 142341139
Market cap (USD): 741597334.1899999
Buyback yield (%): 0.17691541480971137
Capitalized R&D asset: 0
Rule of 40 score: 0